Company / Assets per Share
TherapeuticsMD, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$3.37
FY2024
5-year range
$0.57 / $10.52
FY2020-FY2024
Trend
-26.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.51 in FY2015 to $10.52 in FY2022.
Based on SEC 10-K filings.
3.37 in FY2024 with a 5-year CAGR of +24.9%.
Declined from $10.52 to $3.37 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +81.3%
- 5-Year CAGR
- +24.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, assets per share decreased 26.2% year-over-year.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.37 | -26.2% |
| FY2023 | $4.56 | -56.7% |
| FY2022 | $10.52 | +1760.9% |
| FY2021 | $0.57 | -15.6% |
| FY2020 | $0.67 | -39.5% |
| FY2019 | $1.11 | +12.9% |
| FY2018 | $0.98 | +34.5% |
| FY2017 | $0.73 | -9.1% |
| FY2016 | $0.80 | +57.5% |
| FY2015 | $0.51 | +24.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026